LEADER 05366nam 22006615 450 001 9910616210203321 005 20251113201437.0 010 $a3-031-10992-9 024 7 $a10.1007/978-3-031-10992-8 035 $a(MiAaPQ)EBC7102197 035 $a(Au-PeEL)EBL7102197 035 $a(CKB)24950456400041 035 $a(PPN)264954289 035 $a(OCoLC)1347263542 035 $a(DE-He213)978-3-031-10992-8 035 $a(EXLCZ)9924950456400041 100 $a20220928d2022 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAntibiofilm Strategies $eCurrent and Future Applications to Prevent, Control and Eradicate Biofilms /$fedited by Katharina Richter, Kasper Nørskov Kragh 205 $a1st ed. 2022. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2022. 215 $a1 online resource (569 pages) 225 1 $aSpringer Series on Biofilms,$x1863-9615 ;$v11 311 08$aPrint version: Richter, Katharina Antibiofilm Strategies Cham : Springer International Publishing AG,c2022 9783031109911 327 $aPart 1: Introduction -- Chapter 1: Preface: Biofilms 101 -- Chapter 2: Antimicrobial and innate immune tolerance mechanisms in biofilms -- Chapter 3: Antibiotic resistance development in bacterial biofilms -- Part 2: Biofilm Prevention & Treatment -- Chapter 4: Prevention of biofilms in catheter-associated urinary tract infections -- Chapter 5: Probiotics? action against biofilms -- Chapter 6: Clinical translation of biofilm dispersal agents -- Chapter 7: Chemical regulation of Pseudomonas aeruginosa biofilm formation as a potential treatment for persistent infections -- Chapter 8: Bacteriophages for the treatment of biofilm-associated infections -- Chapter 9: Hyperbaric oxygen treatment may advance the outcome of antibiotic treatment of biofilm infections -- Chapter 10: Cold plasma therapy as a physical antibiofilm approach -- Chapter 11: Antibodies against biofilms: Mechanisms and applications -- Chapter 12: Host defense peptides: Multifront attack on biofilms -- Chapter 13: Learning from nature: Naturally derived remedies -- Chapter 14: Historical medical remedies as potential anti-biofilm approaches: Can we look back to move forward? -- Part 3: Biofilm Control -- Chapter 15: The action of phytochemicals in the control of pathogenic biofilms -- Chapter 16: Current and future applications to control polymicrobial biofilms associated with oral disease -- Chapter 17: Clinical management of fungal biofilm infections -- Chapter 18: Metal-based nanoparticles for biofilm treatment and infection control: From basic research to clinical translation -- Chapter 19: Nitric oxide-mediated dispersal as an adjunctive strategy for the control of biofilm-associated infection -- Chapter 20: Biofouling control in water filtration systems -- Chapter 21: Biofilm in equine and other veterinary wounds. 330 $aBacteria and fungi are able to aggregate together or on surfaces in densely packed microcolonies, facilitated by extracellular polymeric substances for cell protection and stability. These biofilms have proven to be extremely hard to eradicate and remove once established. In chronic infections, this condition can result in a high degree of morbidity and mortality as regular antibiotic treatments are ineffective against biofilms. In industrial facilities, the formation of biofilms can ruin production and result in enormous financial losses. In this book, the current state of antibiofilm research is presented by experts from around the world. Novel, cutting-edge techniques and new optimized strategies based on established methods are discussed in chapters focused on biofilm prevention, treatment and control for the application in clinical, industrial and veterinary settings. Antibiofilm strategies, such as chemical and enzymatic treatments, surface modification and coatings, quorum sensing inhibition and dispersal induction, phage therapy, cold plasma treatment, hyperbaric oxygen treatment, and metal-based nanomedicine are covered, among many others. This book contributes to the UN?s Sustainable Development Goal 3: Good Health and Well-Being and is a valuable resource for healthcare professionals, microbiologists, academics and for educators to inform curricula of universities and colleges. 410 0$aSpringer Series on Biofilms,$x1863-9615 ;$v11 606 $aBiofilms 606 $aMicrobial populations 606 $aMedical microbiology 606 $aVeterinary microbiology 606 $aBiofilms 606 $aMicrobial Communities 606 $aMedical Microbiology 606 $aVeterinary Microbiology 615 0$aBiofilms. 615 0$aMicrobial populations. 615 0$aMedical microbiology. 615 0$aVeterinary microbiology. 615 14$aBiofilms. 615 24$aMicrobial Communities. 615 24$aMedical Microbiology. 615 24$aVeterinary Microbiology. 676 $a579.17 676 $a579.17 702 $aRichter$b Katharina$c(Inscription collector) 702 $aKragh$b Kasper Nørskov 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910616210203321 996 $aAntibiofilm Strategies$92939524 997 $aUNINA